Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/29/2003EP1356120A2 Arrayed polynucleotides and their use in genome analysis
10/29/2003EP1356119A2 The preparation of polynucleotide arrays
10/29/2003EP1356117A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/29/2003EP1356115A1 Methods for detection of chloral hydrate in dichloroacetic acid
10/29/2003EP1356114A2 Brain tumor diagnosis and outcome prediction
10/29/2003EP1356112A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356107A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356106A2 Method for determining skin stress or skin ageing in vitro
10/29/2003EP1356104A2 Methods and probes for detection and/or quantification of nucleic acid sequences
10/29/2003EP1356103A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356099A2 Method and nucleic acids for the analysis of astrocytomas
10/29/2003EP1356097A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356094A2 Methods and compositions for transcription-based nucleic acid amplification
10/29/2003EP1356093A2 Gene markers for lung cancer
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356090A2 Sequence based screening
10/29/2003EP1356088A2 Compositions and methods for array-based nucleic acid hybridization
10/29/2003EP1356085A2 Identification of modulators of dham-kinase and inflammatory diseases
10/29/2003EP1356084A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
10/29/2003EP1356083A2 Methods and compositions for glycosidase assays
10/29/2003EP1356082A2 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
10/29/2003EP1356081A2 Method and device for detecting bacterial contamination
10/29/2003EP1356080A1 Detection and identification of groups of bacteria
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356078A2 Methods for diagnosing and treating pediatric neoplasms
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356051A2 Genes
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355950A1 Antibodies for human cytochrome p450 2d6
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355932A2 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355891A2 Therapy
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355739A2 Method for carrying out a biochemical protocol in continuous flow in a microreactor
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355637A2 Inhibitors of matriptase for the treatment of cancer
10/29/2003EP1355573A2 Lancet device having capillary action
10/29/2003EP1355530A2 Method for the detection of prions in a sample
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1147419B1 Labeling, immobilisation, enrichment, purification and detection of cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls of viruses, bacteria or eukaryotic cells
10/29/2003EP1108212B1 Methods and materials for diagnosing unstable angina
10/29/2003EP1108211B1 Method for testing the toxicity of chemical substances using gastropods
10/29/2003EP1105517B1 Rapid quantitative analysis of proteins or protein function in complex mixtures
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0815458B1 Determining the dielectric properties of wood
10/29/2003EP0796403B1 Functionalized nanotubes
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003CN2583675Y Leather test rotary drum
10/29/2003CN2583674Y Triple contrast experimental rotary drum
10/29/2003CN2583673Y Oval ring restraining cracking automatic monitoring and testing device
10/29/2003CN2583670Y Alcohol detecting warning device
10/29/2003CN1452721A Slide glass having surface treatment layer formed thereon
10/29/2003CN1452719A Method for identifying combinations of drugs
10/29/2003CN1452718A Analyzing device
10/29/2003CN1452665A Diagnostic method for identification of foetal DNA in maternal sample
10/29/2003CN1452664A Improved binding interactions in dipstick assays
10/29/2003CN1452663A Improved detection signal and capture in dipstick assays
10/29/2003CN1452662A Improved capture and detection format versatility for dipstick assays
10/29/2003CN1452661A Viral vectors for use in monitoring HIV drug resistance
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452631A Computer based method for identifying conserved invariant peptide motifs
10/29/2003CN1452629A Skin tissue regeneration prmoters comprising ginsenoside Rb1
10/29/2003CN1452514A Assay device
10/29/2003CN1451965A Method for preparing quick estrogenoid toxicity detecting test piece
10/29/2003CN1451964A Kit for real time fluorescence quantitative RT-RCR detection of human cancer embryoantigen
10/29/2003CN1451963A Gold-label test strip quantitative testing method and system
10/29/2003CN1451955A High-sensitivity carbon fibre cement based resistance strain sensing system comprising temp. compensation
10/29/2003CN1451763A Method for hybrid detecting nucleic acid complex point of shrimp viral
10/29/2003CN1451759A Methylation state of liver cancer related gene promoter CpG island and use thereof
10/29/2003CN1451663A Nucleotide specific to O-antigen of shigella dysenteriae I and Bacillus coli 0121
1 ... 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 ... 3937